ÂÜÀòÂÒÂ×

Charles Winckler is an experienced Chief Financial Officer who has worked with various companies such as NeuroSigma, Monarch BioSciences, Bexson Biomedical, GreenPowerUSA, bioProtonics, Row 44, US Seismic Systems, PBS BioTech, DevZuz Holdings, and Litex. With a Masters in Accounting from the University of Southern California and a B.A. in Business Economics from UC Santa Barbara, Charles is responsible for accounting, financial strategy, audits, tax preparation, human resources, and administrative activities.